Company intelligence / Profile preview

Ohh-Med Medical

Tiberias, Northern District, Israelohhmed.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company's flagship product Vertica has demonstrated over an 85% success rate in clinical studies for improving erectile function. Results were published in the International Journal of Impotence Research. Over 5,000 customers worldwide use Vertica; the device has received CE-MDR approval for Europe and TGA approval for Australia. First insurance reimbursement was achieved in Germany

Therapeutic areas: Men's Health
Modalities: DeviceRadiofrequency-based therapy device (Tissue Restorative Technology)Non-pharmacological therapy
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

Vertica

Commercial

Indications: Erectile dysfunction

1 more asset in the full pipeline.

Request access →

Partnerships

Kaasen MedicalHarp Upson Enterprises

Beyond the preview

Go deeper on Ohh-Med Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ohh-Med Medical.

Explore the full profile